Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Ray Kenney
Observed names:
S.R. Kenney,
S.Ray Kenney,
SR Kenney,
Shelby R. Kenney,
Shelby Ray Kenney
Observed institutions:
University of New Mexico,
University of New Mexico Health Sciences Center
OpenAlex ID:
A5112239602
Characterization of a Cdc42 Protein Inhibitor and Its Use as a Molecular Probe
2013
·
Lin Hong
, S.Ray Kenney
, et al.
·
Journal of Biological Chemistry
·
168
PDF
R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2015
·
Yuna Guo
, S. Ray Kenney
, et al.
·
Molecular Cancer Therapeutics
·
115
A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients
2015
·
Yuna Guo
, S. Ray Kenney
, et al.
·
Clinical Cancer Research
·
68
Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics
2021
·
Christine M. Pauken
, Shelby Ray Kenney
, et al.
·
Cancers
·
25
Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer
2020
·
Debasish Boral
, Haowen N. Liu
, et al.
·
Cancers
·
19
PDF
The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo
2021
·
Martha M. Grimes
, S. Ray Kenney
, et al.
·
BMC Cancer
·
17
PDF
Abstract 4044: R-ketorolac targets Cdc42 and Rac1 GTPases and alters ovarian tumor cell behaviors critical for invasion and metastasis
2015
·
Yuna Guo
, S. Ray Kenney
, et al.
·
Cancer Research
·
14
Characterization of a Cdc42 protein inhibitor and its use as a molecular probe.
2014
·
Lin Hong
, S. Ray Kenney
, et al.
·
Journal of Biological Chemistry
·
4
R-ketorolac as a GTPase inhibitor: Phase 0 intraperitoneal pharmacokinetic and biologic activity in ovarian cancer patients
2014
·
C. Muller
, L.G. Hudson
, et al.
·
Gynecologic Oncology
·
2
Abstract 3159: Rac1 and Cdc42 as drivers in ovarian cancer metastasis
2018
·
Melanie Rivera
, Dayna Dominguez
, et al.
·
Cancer Research
·
1
Data from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Methods from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure Legends from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S3 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Table 1 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Table 2 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S2 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S1 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Methods from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S1 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure Legends from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Table 2 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Table 1 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S2 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Supplementary Figure S3 from R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis
2023
·
Yuna Guo
, S. Ray Kenney
, et al.
Show more works
View as search
Works count:
53
Citation count:
433
H-index:
7
I10-index:
7
Year
Topic
Type